CAJ | 학술논문

目的探讨重组人表皮生长因子治疗白内障超声乳化术后角膜水肿的疗效.方法将56例白内障超声乳化术后并发角膜水肿的患者随机分为两组,对照组采用妥布霉素地塞米松滴眼液等常规治疗,治疗组加用重组人表皮生长因子,观察视力、角膜厚度及角膜水肿消退情况.结果对照组治愈时间为1-9 d,平均4.2 d;治疗组治愈时间为1-4 d,平均1.6 d,治疗组治愈时间明显短于对照组(P＜0.01).结论重组人表皮生长因子在白内障超声乳化术后更有助于角膜水肿的修复.
목적 탐토중조인표피생장인자치료백내장초성유화술후각막수종적료효.방법 장56례백내장초성유화술후병발각막수종적환자수궤분위량조,대조조채용타포매소지새미송적안액등상규치료,치료조가용중조인표피생장인자,관찰시력、각막후도급각막수종소퇴정황.결과 대조조치유시간위1-9 d,평균4.2 d;치료조치유시간위1-4 d,평균1.6 d,치료조치유시간명현단우대조조(P＜0.01).결론 중조인표피생장인자재백내장초성유화술후경유조우각막수종적수복.
Objective To study the recombinant human epidermal growth factor in the treatment of corneal edema after cataract phacoemulsification. Methods Fifty - six cases of complicated cataract surgery corneal edema were randomly divided into two groups, control group using tobramycin and dexam-ethasone eye drops and other conventional treatment, the treatment group received recombinant human epidermal growth factor, observe visual acuity, corneal thickness and corneal edema subsided case. Results In the control group cure time of 1 -9 days, an average of 4.2 days, treatment group cure time of 1-4 days, an average of 1. 6 days, the treatment group healing time was significantly shorter than the control group ( P ＜0.01). Conclusions Recombinant human epidermal growth factor in cataract surgery corneal edema more conducive to the restoration.